Approval · Notice of Compliance 12100 · 2011
ANDROCUR: Notice of Compliance 12100
Issued February 4, 2011
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 12100
- Date
- February 4, 2011
- Company
- Bayer Inc.Elkhart, Indiana, United States
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Revisions to the Contraindications, Overdosage and Toxicology sections of the Product Monograph
- Therapeutic class
- Antiandrogen
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ANDROCUR | Not yet assigned | — |
| ANDROCUR DEPOT | Not yet assigned | — |
Medicinal ingredients
- CYPROTERONE ACETATE 50 MG per TAB
- CYPROTERONE ACETATE 100 MG per ML